Gender- and age-related differences in osteoclast formation from circulating precursors

Journal of Endocrinology

Volumn 172, Issue 3, 2002, Pages 673-681

  Jevon, M ^a   Sabokbar, A ^a   Fujikawa, Y ^a   Hirayama, T ^a   Neale, S D ^a   Wass, J ^a   Athanasou, N A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLONY STIMULATING FACTOR 1; DEXAMETHASONE; DIHYDROXYCOLECALCIFEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; OSTEOCLAST DIFFERENTIATION FACTOR; VITRONECTIN RECEPTOR;

ADULT; AGED; ARTICLE; BONE DISEASE; CELL DIFFERENTIATION; COCULTURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MONONUCLEAR CELL; MULTINUCLEAR CELL; NORMAL HUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PAGET BONE DISEASE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; STEM CELL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; BONE RESORPTION; CALCITRIOL; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OSTEOCLASTS; OSTEOPOROSIS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, VITRONECTIN; RNA-BINDING PROTEINS; SEX FACTORS; TRANSCRIPTION FACTORS;

EID: 0036125938     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1720673     Document Type: Article

References (46)

1. Immunophenotypic differences between osteoclasts and macrophage polykaryons: Immunohistological distinction and implications for osteoclast ontogeny and function
2. Resorption of dentine by isolated osteoclasts in vitro
3. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts
4. Age-related change in resorption cavity characterisation in trabecular bone
5. Age-related changes in bone turnover in men
6. Osteoclast markers accumulate
7. Characterization of an osteoblast-like clonal cell line which responds to both parathyroid and calcitonin
8. The human osteoclast precursor circulates in the monocyte fraction
9. The use of monoclonal antibodies in histological diagnosis
10. Clinical aspects of measurements of plasma vitamin D steroids and the vitamin D binding protein
11. The effect of corticosteroids on human osteoclast formation and activity
12. The roles of osteoprotegerin ligand in the paracrine regulation of bone resorption
13. Monoclonal antibodies for osteoclastomas (giant cell bone tumors): Identification of osteoclast-specific antigens
14. 2 act directly on circulating human osteoclast precursors
15. Cytokines, bone remodelling, and oestrogen deficiency: A 1998 update
16. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function
17. Isolation and hormonal responsiveness of primary human bone-derived cells: Gender and age differences
18. Oestrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via interleukin-1- and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production
19. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
20. Macrophage colony stimulating-factor transcripts are differentially related in rat bone-marrow by gender hormones
21. Regulation of the gp80 and gp130 subunits of the IL-6 receptors by sex steroids in the murine bone marrow
22. Proximal femur bone and mineral levels of US adults
23. Bone marrow, cytokines, and bone remodeling: Emerging insights into the pathophysiology of osteoporosis
24. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures
25. 3 stimulates rat osteoblastic cells to release a soluble factor that increase osteoclastic bone resorption
26. Histomorphometric analysis of normal bone from the iliac crest
27. Physiological senile involution and pathological rarefaction of bone. Quantitative and comparative histological data
28. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function
29. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation
30. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis
31. 3 and RANKL
32. Glucocorticoid-induced osteoporosis: Pathogenesis and management
33. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
34. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation
35. Age-related histomorphometric changes in bone in normal British men and women
36. Dexamethasone promotes expression of membrane-bound macrophage colony-stimulating factor in murine osteoblast-like cells
37. Inhibition of bone resorption by 17β-estradiol in human bone marrow cultures
38. A quantitative histological study on bone resorption in human cancellous bone
39. Age variations in the specific surface of Howship's lacunae as an index of human bone resorption
40. Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression
41. Modulation of osteoclast differentiation
42. Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes
43. Glucocorticoids impair bone resorptive activity and viability of osteoclasts disaggregated from neonatal rat long bones
44. 2, or parathyroid hormone in the microenvironment of bone
45. Origin of osteoclasts: Mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells
46. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL